Tango Biosciences leads the industry with an innovative approach to phage display that delivers highly sensitive, specific, and reproducible custom affinity reagents for your target or antigen. Whether you are developing research tools, diagnostic assays, or therapeutics, Tango Biosciences’ sustainable recombinant affinity reagents and assay development solutions deliver more reliable results faster than any other company.
Our solutions:
• Phage display libraries
• Custom affinity reagents
• Custom binding assays
• Peptide drug discovery
• Protease substrate profiling
Company Details
- Employees
- 6
- Founded
- -
- Address
- 2201 W Campbell Park Dr, Chicago,illinois 60612,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tangobio.com
- Keywords
- phage display, affinity reagents, protein production, assay development, sandwich assays, contract research, peptide drug discovery.
- HQ
- Chicago, Illinois
Tango Biosciences, Inc. Questions
Tango Biosciences, Inc.'s website is http://www.tangobio.com
Tango Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/tangobio
Tango Biosciences, Inc. has
6 employees.
View email and phone details for 6
employees at Tango Biosciences, Inc..
Tango Biosciences, Inc.'s industry is
Biotechnology Research
Tango Biosciences, Inc.'s top competitors are
Bright Minds Biosciences,
Shinobi Therapeutics,
Onl Therapeutics,
Neucyte,
Genentech,
Allterum Therapeutics,
Gempharmatech,
Arc Institute,
Tango Therapeutics,
Epigen Biosciences, Inc..
Tango Biosciences, Inc.'s categories are Biotechnology Research
Tango Biosciences, Inc.'s founding year is 2016
